A full transcript of STARS-ADHD — the pivotal trial of Akili Interactive’s video game-like pediatric attention deficit treatment — has been published in The Lancet Digital Health journal, providing onlookers a clear view of data fueling the digital therapeutic company’s pending FDA submission.
The writeup echoes topline findings first unveiled by the company in December 2017: compared to a...
Health research studies conducted using health research apps are capable of recruiting a large number of participants, but these efforts often see early dropouts and do not enrolls samples representative of the larger population, according to a study published this week in NPJ Digital Medicine.
The investigation, headed by the science research-focused nonprofit Sage Bionetworks, reviewed user...
After partnering with LIVI and launching the Reboot Quiz, Boots UK has announced that it is piloting the Doctor Care Anywhere (DCA) ePrescription service in 20 stores across central London.
Its introduction means that patients will be able to have their prescriptions sent electronically to a Boots pharmacy “within moments” of their consultation.
DCA, which is registered with the Care Quality...
Alto, a digital pharmacy and drug delivery company, will announce next week the close of a $250 million Series D funding round headed by SoftBank’s Vision Fund 2, Reuters and others reported this morning. Greenoaks Capital, Jackson Square Ventures and other prior backers also participated in the round.
This round would bring Alto’s total raise to more than $350 million, and its valuation to more...
Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
While many would agree that healthcare is turning a corner with increasing focus on patient-friendly experiences and the consumerization of healthcare services, not every attempt in this area has been a home run. These shortcomings have been particularly disappointing in the realm of digital, where a successful, well-...
San Francisco-based EHR developer Practice Fusion has agreed to pay $145 million alongside an admission that it “solicited and received kickbacks from a major opioid company” in exchange for clinical decision support (CDS) alerts promoting unnecessary prescription opioids, according to a release from the US Department of Justice.
In a settlement announced yesterday (and hinted at in an earnings...
Unfortunately for us, MobiHealthNews doesn’t have a crystal ball (it would be darn useful for getting scoops). But we do have more than a decade’s worth of experience tracking the emergence of this space and we spend a lot of our time talking to smart people with industry experience and opinions of their own.
As we enter into a new decade in 2020, your MobiHealthNews staff has put our heads...
Update: HIMSS20 has been canceled due to the coronavirus. Read more here.
About the author: Naomi Fried, PhD, is the CEO of Health Innovation Strategies, which provides digital health strategy and innovation-program design and optimization consulting to healthcare stakeholders including pharma, payers and providers. Her previous positions include the first chief innovation officer at Boston...
Editor's note: This story has been updated with information from Verily's announcement of the clearance.
Verily, the life sciences research subsidiary of Alphabet, has received FDA 510(k) clearance for an augmented version of its prescription Study Watch wearable that includes some form of arrhythmia monitoring.
The Study Watch With Irregular Pulse Monitor is classified by the FDA as a “...